92 related articles for article (PubMed ID: 301432)
1. Approaches for the isolation of biologically functional tumor-associated antigens.
Reisfeld RA; David GS; Ferrone S; Pellegrino MA; Holmes EC
Cancer Res; 1977 Aug; 37(8 Pt 2):2860-5. PubMed ID: 301432
[TBL] [Abstract][Full Text] [Related]
2. Purification and immunologic evaluation of human melnoma-associated antigens.
McCabe RP; Ferrone S; Pellegrino MA; Kern DH; Holmes EC; Reisfeld RA
J Natl Cancer Inst; 1978 Apr; 60(4):773-7. PubMed ID: 75978
[TBL] [Abstract][Full Text] [Related]
3. Purification of soluble human melanoma-associated antigens.
Roth JA; Slocum HK; Pellegrino MA; Holmes EC; Reisfeld RA
Cancer Res; 1976 Jul; 36(7 PT 1):2360-4. PubMed ID: 776393
[TBL] [Abstract][Full Text] [Related]
4. Class 1 (unique) tumor antigens of human melanoma: partial purification and characterization of the FD antigen and analysis of a mouse polyclonal antiserum.
Mattes MJ; Real FX; Furukawa K; Old LJ; Lloyd KO
Cancer Res; 1987 Dec; 47(24 Pt 1):6614-9. PubMed ID: 2445475
[TBL] [Abstract][Full Text] [Related]
5. Isolation and immunochemical characterization of antibodies from the sera of cancer patients which are reactive against human melanoma cell membranes by affinity chromatography.
Gupta RK; Silver HK; Reisfeld RA; Morton DL
Cancer Res; 1979 May; 39(5):1683-95. PubMed ID: 427806
[TBL] [Abstract][Full Text] [Related]
6. Classes I and II HLA and melanoma-associated antigen expression and modulation on melanoma cells isolated from primary and metastatic lesions.
Taramelli D; Fossati G; Mazzocchi A; Delia D; Ferrone S; Parmiani G
Cancer Res; 1986 Jan; 46(1):433-9. PubMed ID: 3079589
[TBL] [Abstract][Full Text] [Related]
7. Immunoassay for melanoma-associated proteoglycan in the sera of patients using monoclonal and polyclonal antibodies.
Ross AH; Herlyn M; Ernst CS; Guerry D; Bennicelli J; Ghrist BF; Atkinson B; Koprowski H
Cancer Res; 1984 Oct; 44(10):4642-7. PubMed ID: 6380710
[TBL] [Abstract][Full Text] [Related]
8. [Isolation of soluble tumor-associated antigens of human malignant melanoma].
Suter L
Fortschr Med; 1978 Aug; 96(32):1615-8. PubMed ID: 680624
[TBL] [Abstract][Full Text] [Related]
9. Molecular profiles of human melanoma-associated antigens.
Galloway DR; Imai K; Ferrone S; Reisfeld RA
Fed Proc; 1981 Feb; 40(2):231-6. PubMed ID: 7461145
[TBL] [Abstract][Full Text] [Related]
10. Identification and purification of a Mr 75,000 cell surface human melanoma-associated antigen.
Heaney-Kieras J; Bystryn JC
Cancer Res; 1982 Jun; 42(6):2310-6. PubMed ID: 7042082
[TBL] [Abstract][Full Text] [Related]
11. Association of melanoma tumor antigen activity with beta2-microglobulin.
Malley A; Burger DR; Vandenbark AA; Frikke M; Finke P; Begley D; Acott K; Black J; Vetto RM
Cancer Res; 1979 Feb; 39(2 Pt 2):619-23. PubMed ID: 83915
[TBL] [Abstract][Full Text] [Related]
12. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
Kageshita T; Ishihara T; Campoli M; Ferrone S
Tissue Antigens; 2005 May; 65(5):419-28. PubMed ID: 15853896
[TBL] [Abstract][Full Text] [Related]
13. Human tumor-associated antigens defined by monoclonal antibodies.
Reisfeld RA; Harper JR; Bumol TF
Crit Rev Immunol; 1984; 5(1):27-53. PubMed ID: 6400468
[TBL] [Abstract][Full Text] [Related]
14. Immunopurification, characterization, and nature of membrane association of human melanoma-associated oncofetal antigen gp87 defined by monoclonal antibody 140.240.
Liao SK; Kwong PC; Khosravi MJ
J Cell Biochem; 1985; 27(3):303-16. PubMed ID: 3886678
[TBL] [Abstract][Full Text] [Related]
15. Production of melanoma-associated antigen(s) by a defined malignant melanoma cell strain grown in chemically defined medium.
Chee DO; Boddie AW; Roth JA; Holmes EC; Morton DL
Cancer Res; 1976 Apr; 36(4):1503-9. PubMed ID: 1260767
[TBL] [Abstract][Full Text] [Related]
16. Indirect rosette microassay to characterize human melanoma-associated antigens recognized by operationally specific xenoantisera.
Imai K; Ferrone S
Cancer Res; 1980 Jul; 40(7):2252-6. PubMed ID: 6966965
[TBL] [Abstract][Full Text] [Related]
17. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
Elder DE; Rodeck U; Thurin J; Cardillo F; Clark WH; Stewart R; Herlyn M
Cancer Res; 1989 Sep; 49(18):5091-6. PubMed ID: 2548711
[TBL] [Abstract][Full Text] [Related]
18. Naturally soluble tumor antigens from guinea pig hepatomas: isolation and partial characterization.
Detrick-Hooks B; Smith HG; Bast RC; Dunkel VC; Borsos T
J Immunol; 1976 May; 116(5):1324-31. PubMed ID: 178795
[TBL] [Abstract][Full Text] [Related]
19. Compartmental distribution of tumor-specific monoclonal antibodies in human melanoma xenografts.
Lin K; Nagy JA; Xu H; Shockley TR; Yarmush ML; Dvorak HF
Cancer Res; 1994 Apr; 54(8):2269-77. PubMed ID: 8174137
[TBL] [Abstract][Full Text] [Related]
20. Defective antigen presentation by human melanoma cell lines cultured from advanced, but not biologically early, disease.
Alexander MA; Bennicelli J; Guerry D
J Immunol; 1989 Jun; 142(11):4070-8. PubMed ID: 2469732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
